Chapter/Section Purchase

1 Study Coverage
1.1 Lyme Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Lyme Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Lyme Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lyme Disease Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Lyme Disease Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Lyme Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lyme Disease Vaccine Sales by Region
2.4.1 Global Lyme Disease Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Lyme Disease Vaccine by Region (2023-2028)
2.5 Global Lyme Disease Vaccine Revenue by Region
2.5.1 Global Lyme Disease Vaccine Revenue by Region (2017-2022)
2.5.2 Global Lyme Disease Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lyme Disease Vaccine Sales by Manufacturers
3.1.1 Global Top Lyme Disease Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Lyme Disease Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lyme Disease Vaccine in 2021
3.2 Global Lyme Disease Vaccine Revenue by Manufacturers
3.2.1 Global Lyme Disease Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Lyme Disease Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lyme Disease Vaccine Revenue in 2021
3.3 Global Lyme Disease Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lyme Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lyme Disease Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lyme Disease Vaccine Sales by Type
4.1.1 Global Lyme Disease Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Lyme Disease Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Lyme Disease Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Lyme Disease Vaccine Revenue by Type
4.2.1 Global Lyme Disease Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Lyme Disease Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lyme Disease Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Lyme Disease Vaccine Price by Type
4.3.1 Global Lyme Disease Vaccine Price by Type (2017-2022)
4.3.2 Global Lyme Disease Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lyme Disease Vaccine Sales by Application
5.1.1 Global Lyme Disease Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Lyme Disease Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Lyme Disease Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Lyme Disease Vaccine Revenue by Application
5.2.1 Global Lyme Disease Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Lyme Disease Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lyme Disease Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Lyme Disease Vaccine Price by Application
5.3.1 Global Lyme Disease Vaccine Price by Application (2017-2022)
5.3.2 Global Lyme Disease Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lyme Disease Vaccine Market Size by Type
6.1.1 North America Lyme Disease Vaccine Sales by Type (2017-2028)
6.1.2 North America Lyme Disease Vaccine Revenue by Type (2017-2028)
6.2 North America Lyme Disease Vaccine Market Size by Application
6.2.1 North America Lyme Disease Vaccine Sales by Application (2017-2028)
6.2.2 North America Lyme Disease Vaccine Revenue by Application (2017-2028)
6.3 North America Lyme Disease Vaccine Market Size by Country
6.3.1 North America Lyme Disease Vaccine Sales by Country (2017-2028)
6.3.2 North America Lyme Disease Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Lyme Disease Vaccine Market Size by Type
7.1.1 Europe Lyme Disease Vaccine Sales by Type (2017-2028)
7.1.2 Europe Lyme Disease Vaccine Revenue by Type (2017-2028)
7.2 Europe Lyme Disease Vaccine Market Size by Application
7.2.1 Europe Lyme Disease Vaccine Sales by Application (2017-2028)
7.2.2 Europe Lyme Disease Vaccine Revenue by Application (2017-2028)
7.3 Europe Lyme Disease Vaccine Market Size by Country
7.3.1 Europe Lyme Disease Vaccine Sales by Country (2017-2028)
7.3.2 Europe Lyme Disease Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lyme Disease Vaccine Market Size by Type
8.1.1 Asia Pacific Lyme Disease Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Lyme Disease Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Lyme Disease Vaccine Market Size by Application
8.2.1 Asia Pacific Lyme Disease Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Lyme Disease Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Lyme Disease Vaccine Market Size by Region
8.3.1 Asia Pacific Lyme Disease Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Lyme Disease Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Lyme Disease Vaccine Market Size by Type
9.1.1 Latin America Lyme Disease Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Lyme Disease Vaccine Revenue by Type (2017-2028)
9.2 Latin America Lyme Disease Vaccine Market Size by Application
9.2.1 Latin America Lyme Disease Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Lyme Disease Vaccine Revenue by Application (2017-2028)
9.3 Latin America Lyme Disease Vaccine Market Size by Country
9.3.1 Latin America Lyme Disease Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Lyme Disease Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lyme Disease Vaccine Market Size by Type
10.1.1 Middle East and Africa Lyme Disease Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lyme Disease Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Lyme Disease Vaccine Market Size by Application
10.2.1 Middle East and Africa Lyme Disease Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lyme Disease Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Lyme Disease Vaccine Market Size by Country
10.3.1 Middle East and Africa Lyme Disease Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lyme Disease Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Merial
11.2.1 Merial Corporation Information
11.2.2 Merial Overview
11.2.3 Merial Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merial Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merial Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lyme Disease Vaccine Industry Chain Analysis
12.2 Lyme Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lyme Disease Vaccine Production Mode & Process
12.4 Lyme Disease Vaccine Sales and Marketing
12.4.1 Lyme Disease Vaccine Sales Channels
12.4.2 Lyme Disease Vaccine Distributors
12.5 Lyme Disease Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lyme Disease Vaccine Industry Trends
13.2 Lyme Disease Vaccine Market Drivers
13.3 Lyme Disease Vaccine Market Challenges
13.4 Lyme Disease Vaccine Market Restraints
14 Key Findings in The Global Lyme Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer